UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), generalized myasthenia gravis...